Mesenchymal stem cells (MSCs) can be derived from multiple tissue sources. However, the
optimal source of MSCs for cell-based therapy for acute lung injury (ALI) is unclear. In the …

Cell therapy has achieved tremendous success in regenerative medicine in the past several
decades. However, challenges such as cell loss, death and immune-rejection after …

Osteogenesis imperfecta (OI) is caused by dominant mutations in the type I collagen genes.
In principle, the skeletal abnormalities of OI could be treated by transplantation of patient …

Current meniscus tissue repairing strategies involve partial or total meniscectomy, followed
by allograft transplantation or synthetic material implantation. However, allografts and …

Cardiomyocytes (CMs) and mesenchymal stem cells (MSCs) are important cell types for
cardiac repair post myocardial infarction. Here we proved that both CMs and MSCs can be …

Hydrogels have numerous biomedical applications including synthetic matrices for cell
culture and tissue engineering. Here we report the development of hydrogel based …

Embryonic stem cells (ESCs) and mesenchymal stem cells (MSCs) have been studied for
years as primary cell sources for regenerative biology and medicine. MSCs have been …

Mesenchymal stem/stromal cells (MSCs) have great clinical potential in modulating
inflammation and promoting tissue repair. Human embryonic stem cells (hESCs) have …

Background Mesenchymal stem/stromal cells (MSCs) derived from human embryonic stem
cells (hESCs) are attractive for their hematopoietic-supporting or potential therapeutic …

Multilineage tissue-source mesenchymal stem cells (MSCs) possess strong
immunomodulatory properties and are excellent therapeutic agents, but require constant …